Treatment of Menstrual Cramping
Start with NSAIDs as first-line therapy: ibuprofen 600-800 mg every 6-8 hours or naproxen 440-550 mg every 12 hours, taken with food for 5-7 days during menstruation only. 1, 2, 3, 4
First-Line Pharmacological Treatment
NSAIDs are the mainstay of treatment because they inhibit prostaglandin synthesis, which drives dysmenorrhea pain through uterine hypercontractility and ischemia. 2
Specific dosing regimens:
- Ibuprofen 600-800 mg every 6-8 hours with food (higher doses are more effective than lower doses in clinical practice) 2, 3, 4
- Naproxen 440-550 mg every 12 hours with food 1, 2, 3
- Mefenamic acid for 5-day treatment courses 3
- Treatment duration: 5-7 days during bleeding only 1, 2, 3, 4
- Maximum daily ibuprofen dose: 3200 mg, though doses above 400 mg every 4-6 hours show no additional benefit for pain relief 4
Critical: Do not underdose NSAIDs—use the full therapeutic doses of 600-800 mg ibuprofen, not the lower 400 mg dose commonly used. 2
Adjunctive Non-Pharmacological Measures
These can be used alongside NSAIDs from the start:
- Heat therapy applied to the abdomen or back reduces cramping pain 1, 2, 3
- Acupressure at specific anatomical points: Large Intestine-4 (LI4) on the dorsum of the hand and Spleen-6 (SP6) located approximately 4 fingers above the medial malleolus 1, 2, 3
- Peppermint essential oil has demonstrated symptom reduction 1, 2, 3
Second-Line Treatment: When NSAIDs Fail
If NSAIDs fail after 2-3 menstrual cycles or are contraindicated, add hormonal contraceptives. 1, 2
Approximately 18% of women are unresponsive to NSAIDs, which should prompt investigation for secondary causes. 1, 3
Hormonal contraceptive options:
- Combined oral contraceptives (COCs) with 30-35 μg ethinyl estradiol plus levonorgestrel or norgestimate 2, 3
- COCs provide additional benefits: decreased menstrual blood loss, improvement in acne, completely reversible with no negative effect on long-term fertility 3
- Extended or continuous cycles of COCs are particularly appropriate for severe dysmenorrhea as they minimize hormone-free intervals and optimize ovarian suppression 3
- Use monophasic formulations for simplicity 3
When to Investigate for Secondary Causes
Obtain transvaginal ultrasound if:
- Abnormal pelvic examination findings are present 1, 2
- Symptoms suggest secondary dysmenorrhea 1, 2
- Failure to respond to appropriate NSAID therapy after 2-3 menstrual cycles 1, 2
- Abrupt change in previously stable pain pattern 1
Rule out the following pathologies:
- Endometriosis, adenomyosis, fibroids, polyps, and other structural uterine pathology 1, 2
- IUD displacement in patients with worsening dysmenorrhea 1
- Sexually transmitted diseases and chronic pelvic inflammatory disease 1, 2
- Pregnancy 2, 3
Management of Suspected Endometriosis
Hormonal contraceptives are first-line for endometriosis-related dysmenorrhea. 1, 2, 3
If endometriosis is confirmed and medical management fails:
- GnRH agonists for at least 3 months with add-back therapy (prevents bone mineral loss without reducing efficacy) 1, 3
- Danazol for at least 6 months 1, 3
- Medical therapy alone may be insufficient for severe endometriosis 1
Treatment Algorithm for Refractory Cases
Escalation pathway when symptoms persist beyond 3 months despite appropriate therapy: 3
- NSAIDs for 2-3 cycles
- Add hormonal contraceptives if inadequate response
- Evaluate for secondary causes with pelvic ultrasound
- Consider medical management with progestins, danazol, oral contraceptives, or GnRH agonists if endometriosis is suspected
- Referral to gynecologic specialist for possible laparoscopy evaluation
Critical Pitfalls to Avoid
- Do not delay NSAID treatment while waiting for diagnostic workup—start empiric therapy immediately 2
- Do not underdose NSAIDs—use full therapeutic doses of 600-800 mg ibuprofen or 440-550 mg naproxen 2
- Do not continue ineffective treatment beyond 2-3 cycles—this indicates need for investigation of secondary causes 2
- Do not forget to rule out STDs, such as chronic pelvic inflammatory disease, which can present as worsening dysmenorrhea 1, 2
- Do not use combined oral contraceptives to mask symptoms without first attempting to identify underlying pathology in treatment-refractory cases 2